{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:32:06Z","timestamp":1787239926369,"version":"build-2736575974"},"reference-count":109,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>The international community has committed to ending the tuberculosis (TB) epidemic by 2030. This will require multi-sectoral action with a focus on accelerating socio-economic development, developing and implementing new tools, and expanding health insurance coverage. Within this broad framework, National TB Programmes (NTPs) are accountable for delivering diagnostic, treatment, and preventive services. There are large gaps in the delivery of these services, and the aim of this article is to review the crucial activities and interventions that NTPs must implement in order to meet global targets and milestones that will end the TB epidemic. The key deliverables are the following: turn End TB targets and milestones into national measurable indicators to make it easier to track progress; optimize the prompt and accurate diagnosis of all types of TB; provide rapid, complete, and effective treatment to all those diagnosed with TB; implement and monitor effective infection control practices; diagnose and treat drug-resistant TB, associated HIV infection, and diabetes mellitus; design and implement active case finding strategies for high-risk groups and link them to the treatment of latent TB infection; engage with the private-for-profit sector; and empower the Central Unit of the NTP particularly in relation to data-driven supportive supervision, operational research, and sustained financing. The glaring gaps in the delivery of TB services must be remedied, and some of these gaps will require new paradigms and ways of working which include patient-centered and higher-quality services. There must also be fast-track ways of incorporating new diagnostic, treatment, and prevention tools into program activities so as to rapidly reduce TB incidence and mortality and meet the goal of ending TB by 2030.<\/ns4:p>","DOI":"10.12688\/f1000research.14821.1","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T16:35:09Z","timestamp":1530808509000},"page":"1011","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?"],"prefix":"10.12688","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6113-9741","authenticated-orcid":false,"given":"Anthony D.","family":"Harries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7055-3183","authenticated-orcid":false,"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay M.V.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinath","family":"Satyanarayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kudakwashe C.","family":"Takarinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta A.","family":"Dlodlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2915-9328","authenticated-orcid":false,"given":"Rony","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero L.","family":"Olliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"key":"ref-1","article-title":"Transforming our world: the 2030 agenda for sustainable development","year":"2015"},{"key":"ref-2","article-title":"The End TB Strategy","year":"2015"},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"523-5","DOI":"10.7861\/clinmedicine.6-6-523","article-title":"Tuberculosis: where are we going?","volume":"6","author":"G Thwaites","year":"2006","journal-title":"Clin Med (Lond)."},{"key":"ref-4","article-title":"Global Tuberculosis Report","year":"2016"},{"key":"ref-5","article-title":"Global Tuberculosis Report","year":"2017"},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"1148-54","DOI":"10.5588\/ijtld.16.0142","article-title":"Ending tuberculosis by 2030: can we do it?","volume":"20","author":"A Suthar","year":"2016","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"1393-4","DOI":"10.1001\/jama.2014.11450","article-title":"Global tuberculosis: perspectives, prospects, and priorities.","volume":"312","author":"T Frieden","year":"2014","journal-title":"JAMA."},{"key":"ref-8","article-title":"90-90-90. An ambitious treatment target to help end the AIDS epidemic","year":"2014"},{"key":"ref-9","article-title":"The Paradigm Shift. 2016-2020. Global Plan to End TB.","year":"2016"},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"1163-6","DOI":"10.1136\/bmj.329.7475.1163","article-title":"Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis.","volume":"329","author":"A Harries","year":"2004","journal-title":"BMJ."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"1005-15","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance.","volume":"363","author":"C Boehme","year":"2010","journal-title":"N Engl J Med."},{"key":"ref-12","article-title":"Xpert MTB\/RIF assay for diagnosis of pulmonary and extra-pulmonary TB in adults and children.","year":"2013"},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"1567-72","DOI":"10.5588\/ijtld.11.0392","article-title":"Xpert\u00ae MTB\/RIF for national tuberculosis programmes in low-income countries: when, where and how?","volume":"15","author":"A Tr\u00e9bucq","year":"2011","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-14","first-page":"30-4","article-title":"Impact of Laboratory Practice Changes on the Diagnosis of Tuberculosis with the Introduction of Xpert MTB\/RIF in Kiribati.","volume":"77","author":"A Tonganibeia","year":"2018","journal-title":"Hawaii J Med Public Health."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"264-72","DOI":"10.5588\/ijtld.17.0491","article-title":"Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa.","volume":"22","author":"P Kweza","year":"2018","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"8-10","DOI":"10.1016\/S1473-3099(17)30695-3","article-title":"Performance of Xpert MTB\/RIF Ultra: a matter of dead or alive.","volume":"18","author":"S Arend","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"ref-17","article-title":"WHO Meeting Report of a Technical Expert Consultation: Non-inferiority analysis of Xpert MTB\/RIF Ultra compared to Xpert MTB\/RIF","year":"2017"},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"76-84","DOI":"10.1016\/S1473-3099(17)30691-6","article-title":"Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.","volume":"18","author":"S Dorman","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"ref-19","article-title":"What to consider before Xpert Omni Implementation."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"126-38","DOI":"10.2471\/BLT.13.124800","article-title":"Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis.","volume":"92","author":"P MacPherson","year":"2014","journal-title":"Bull World Health Organ."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"e1002238","DOI":"10.1371\/journal.pmed.1002238","article-title":"Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB\/RIF in South Africa: A retrospective cohort study.","volume":"14","author":"H Cox","year":"2017","journal-title":"PLoS Med."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"378-84","DOI":"10.5588\/ijtld.17.0676","article-title":"Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon.","volume":"22","author":"E Onyoh","year":"2018","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"385-92","DOI":"10.5588\/ijtld.17.0452","article-title":"Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?","volume":"22","author":"K Htet","year":"2018","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-24","first-page":"138-44","article-title":"Performance-related allowances within the Malawi National Tuberculosis Control Programme.","volume":"9","author":"A Harries","year":"2005","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"511-3","DOI":"10.1016\/j.trstmh.2012.05.002","article-title":"High initial default in patients with smear-positive pulmonary tuberculosis at a regional hospital in Accra, Ghana.","volume":"106","author":"F Afutu","year":"2012","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"ref-26","article-title":"Treatment of Tuberculosis Guidelines","year":"2009"},{"key":"ref-27","article-title":"Treatment of Tuberculosis. Guidelines for treatment of drug-susceptible tuberculosis and patient care"},{"key":"ref-28","article-title":"Definitions and reporting framework for tuberculosis \u2013 2013 revision"},{"key":"ref-29","article-title":"Global Tuberculosis Report","year":"2015"},{"key":"ref-30","first-page":"666-71","article-title":"Outcome of patients with tuberculosis who transfer between reporting units in Malawi.","volume":"6","author":"S Meijnen","year":"2002","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1186\/1471-2458-12-981","article-title":"Characteristics and treatment outcomes of tuberculosis patients who \"transfer-in\" to health facilities in Harare City, Zimbabwe: a descriptive cross-sectional study.","volume":"12","author":"K Takarinda","year":"2012","journal-title":"BMC Public Health."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"S108-13","DOI":"10.1086\/518661","article-title":"Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment.","volume":"196 Suppl 1","author":"N Bock","year":"2007","journal-title":"J Infect Dis."},{"key":"ref-33","first-page":"949-54","article-title":"Tuberculosis risk among staff of a large public hospital in Kenya.","volume":"12","author":"T Galgalo","year":"2008","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"291-360","DOI":"10.1016\/S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.","volume":"5","author":"K Dheda","year":"2017","journal-title":"Lancet Respir Med."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"243-53","DOI":"10.1056\/NEJMoa1604544","article-title":"Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.","volume":"376","author":"N Shah","year":"2017","journal-title":"N Engl J Med."},{"key":"ref-36","article-title":"WHO policy on TB infection control in health-care facilities, congregate settings and households","year":"2009"},{"key":"ref-37","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy190","article-title":"Turning off the tap: Using the FAST approach to stop the spread of drug-resistant tuberculosis in Russian Federation.","author":"A Miller","year":"2018","journal-title":"J Infect Dis."},{"key":"ref-38","article-title":"Guidelines for the programmatic management of drug-resistant tuberculosis 2011 Update"},{"key":"ref-39","article-title":"WHO treatment guidelines for drug-resistant tuberculosis, 2016 Update"},{"key":"ref-40","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00544-2018","article-title":"Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa.","volume":"51","author":"O Olayanju","year":"2018","journal-title":"Eur Respir J."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"197-205","DOI":"10.5588\/ijtld.17.0254","article-title":"Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.","volume":"22","author":"E Pavlenko","year":"2018","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-42","first-page":"204-10","article-title":"Using a bus service for transporting sputum specimens to the Central Reference Laboratory: effect on the routine TB culture service in Malawi.","volume":"8","author":"A Harries","year":"2004","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"156-9","DOI":"10.5588\/pha.12.0103","article-title":"Are sputum samples of retreatment tuberculosis reaching the reference laboratories? A 9-year audit in Tanzania.","volume":"3","author":"A Kilale","year":"2013","journal-title":"Public Health Action."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"e26659","DOI":"10.1371\/journal.pone.0026659","article-title":"Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India.","volume":"6","author":"S Chadha","year":"2011","journal-title":"PLoS One."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"122-8","DOI":"10.5588\/pha.16.0005","article-title":"Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert\u00ae MTB\/RIF in Zimbabwe.","volume":"6","author":"K Charambira","year":"2016","journal-title":"Public Health Action."},{"key":"ref-46","article-title":"The Shorter MDR-TB Regimen","year":"2016"},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"684-92","DOI":"10.1164\/rccm.201001-0077OC","article-title":"Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis.","volume":"182","author":"A van Deun","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"17-25","DOI":"10.5588\/ijtld.17.0498","article-title":"Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.","volume":"22","author":"A Tr\u00e9bucq","year":"2018","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-49","article-title":"The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin Policy Update","year":"2016"},{"key":"ref-50","article-title":"The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs. Policy Guidance","year":"2016"},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"1043-54","DOI":"10.1056\/NEJMoa1614915","article-title":"Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.","volume":"377","author":"Y Xie","year":"2017","journal-title":"N Engl J Med."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"670-6","DOI":"10.5588\/ijtld.16.0843","article-title":"Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.","volume":"21","author":"Y van der Heijden","year":"2017","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-53","article-title":"WHO treatment guidelines for isoniazid-resistant tuberculosis Supplement to the WHO Treatment Guidelines for Drug-resistant Tuberculosis","year":"2018"},{"key":"ref-54","doi-asserted-by":"crossref","first-page":"143-52","DOI":"10.1097\/00002030-200101260-00002","article-title":"Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa.","volume":"15","author":"Y Mukadi","year":"2001","journal-title":"AIDS."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"571-81","DOI":"10.5588\/ijtld.10.0483","article-title":"Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?","volume":"15","author":"S Lawn","year":"2011","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"e137-50","DOI":"10.1016\/S2352-3018(15)00005-3","article-title":"Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.","volume":"2","author":"A Suthar","year":"2015","journal-title":"Lancet HIV."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"S238-44","DOI":"10.1086\/651497","article-title":"Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned.","volume":"50 Suppl 3","author":"A Howard","year":"2010","journal-title":"Clin Infect Dis."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"228-45","DOI":"10.1177\/1742395307081502","article-title":"Diabetes and the risk of tuberculosis: a neglected threat to public health?","volume":"3","author":"C Stevenson","year":"2007","journal-title":"Chronic Illn."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.","volume":"5","author":"C Jeon","year":"2008","journal-title":"PLoS Med."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"730-9","DOI":"10.1016\/S2213-8587(14)70109-3","article-title":"Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice.","volume":"2","author":"K L\u00f6nnroth","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-9-81","article-title":"The impact of diabetes on tuberculosis treatment outcomes: a systematic review.","volume":"9","author":"M Baker","year":"2011","journal-title":"BMC Med."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"822-9","DOI":"10.1111\/tmi.12120","article-title":"Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania.","volume":"18","author":"D Faurholt-Jepsen","year":"2013","journal-title":"Trop Med Int Health."},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"e58044","DOI":"10.1371\/journal.pone.0058044","article-title":"Impact of diabetes and smoking on mortality in tuberculosis.","volume":"8","author":"G Reed","year":"2013","journal-title":"PLoS One."},{"key":"ref-64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01213-5","article-title":"Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis.","volume":"7","author":"Q Liu","year":"2017","journal-title":"Sci Rep."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"e0175925","DOI":"10.1371\/journal.pone.0175925","article-title":"Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review.","volume":"12","author":"M Workneh","year":"2017","journal-title":"PLoS One."},{"key":"ref-66","article-title":"Collaborative Framework for Care and Control of Tuberculosis and Diabetes","year":"2011"},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"1294-301","DOI":"10.1111\/j.1365-3156.2012.03068.x","article-title":"Screening of patients with tuberculosis for diabetes mellitus in China.","volume":"17","author":"L Li","year":"2012","journal-title":"Trop Med Int Health."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"636-45","DOI":"10.1111\/tmi.12084","article-title":"Screening of patients with tuberculosis for diabetes mellitus in India.","volume":"18","year":"2013","journal-title":"Trop Med Int Health."},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"376-82","DOI":"10.5588\/ijtld.15.0654","article-title":"Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?","volume":"20","author":"H Lo","year":"2016","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"198-205","DOI":"10.1093\/cid\/cix819","article-title":"Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.","volume":"66","author":"N Degner","year":"2018","journal-title":"Clin Infect Dis."},{"key":"ref-71","article-title":"IDF Diabetes Atlas","year":"2017"},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"374-8","DOI":"10.1016\/j.ijmyco.2016.09.023","article-title":"Passive case finding for tuberculosis is not enough.","volume":"5","author":"J Ho","year":"2016","journal-title":"Int J Mycobacteriol."},{"key":"ref-73","article-title":"Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries","year":"2012"},{"key":"ref-74","article-title":"Systematic Screening for Active Tuberculosis: Principles and Recommendations","year":"2013"},{"key":"ref-75","doi-asserted-by":"publisher","first-page":"93-102","DOI":"10.1016\/S1473-3099(09)70326-3","article-title":"Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis.","volume":"10","author":"K Kranzer","year":"2010","journal-title":"Lancet Infect Dis."},{"key":"ref-76","doi-asserted-by":"publisher","first-page":"e1000381","DOI":"10.1371\/journal.pmed.1000381","article-title":"Tuberculosis incidence in prisons: a systematic review.","volume":"7","author":"I Baussano","year":"2010","journal-title":"PLoS Med."},{"key":"ref-77","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1371\/journal.pmed.0030494","article-title":"Tuberculosis among health-care workers in low- and middle-income countries: a systematic review.","volume":"3","author":"R Joshi","year":"2006","journal-title":"PLoS Med."},{"key":"ref-78","doi-asserted-by":"publisher","first-page":"1302-8","DOI":"10.1111\/j.1365-3156.2012.03069.x","article-title":"Screening patients with diabetes mellitus for tuberculosis in China.","volume":"17","author":"Y Lin","year":"2012","journal-title":"Trop Med Int Health."},{"key":"ref-79","doi-asserted-by":"publisher","first-page":"646-54","DOI":"10.1111\/tmi.12083","article-title":"Screening of patients with diabetes mellitus for tuberculosis in India.","volume":"18","year":"2013","journal-title":"Trop Med Int Health."},{"key":"ref-80","doi-asserted-by":"publisher","first-page":"1987-2002","DOI":"10.1097\/QAD.0000000000000802","article-title":"Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis.","volume":"29","author":"R Gupta","year":"2015","journal-title":"AIDS."},{"key":"ref-81","doi-asserted-by":"publisher","first-page":"201-9","DOI":"10.1016\/S1473-3099(11)70251-1","article-title":"Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.","volume":"12","author":"S Lawn","year":"2012","journal-title":"Lancet Infect Dis."},{"key":"ref-82","doi-asserted-by":"publisher","first-page":"1187-97","DOI":"10.1016\/S0140-6736(15)01092-2","article-title":"Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.","volume":"387","author":"J Peter","year":"2016","journal-title":"Lancet."},{"key":"ref-83","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12916-015-0432-2","article-title":"Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB\/RIF: a prospective cohort in South Africa.","volume":"13","author":"S Lawn","year":"2015","journal-title":"BMC Med."},{"key":"ref-84","article-title":"Urine-based screening for tuberculosis: a randomized trial in HIV-positive inpatients","author":"A Gupta-Wright","year":"2018"},{"key":"ref-85","doi-asserted-by":"publisher","first-page":"140-56","DOI":"10.1183\/09031936.00070812","article-title":"Contact investigation for tuberculosis: a systematic review and meta-analysis.","volume":"41","author":"G Fox","year":"2013","journal-title":"Eur Respir J."},{"key":"ref-86","doi-asserted-by":"publisher","first-page":"221-9","DOI":"10.1056\/NEJMoa1700209","article-title":"Household-Contact Investigation for Detection of Tuberculosis in Vietnam.","volume":"378","author":"G Fox","year":"2018","journal-title":"N Engl J Med."},{"key":"ref-87","doi-asserted-by":"publisher","first-page":"2127-35","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection.","volume":"372","author":"H Getahun","year":"2015","journal-title":"N Engl J Med."},{"key":"ref-88","first-page":"927-35","article-title":"Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.","volume":"13","author":"N A\u00eft-Khaled","year":"2009","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-89","article-title":"Latent tuberculosis infection. Updated and consolidated guidelines for programmatic management","year":"2018"},{"key":"ref-90","doi-asserted-by":"publisher","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","article-title":"Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.","volume":"9","author":"A Suthar","year":"2012","journal-title":"PLoS Med."},{"key":"ref-91","doi-asserted-by":"publisher","first-page":"103-5","DOI":"10.5588\/pha.15.0008","article-title":"Declining tuberculosis notification trend associated with strengthened TB and expanded HIV care in Swaziland.","volume":"5","author":"S Haumba","year":"2015","journal-title":"Public Health Action."},{"key":"ref-92","doi-asserted-by":"publisher","first-page":"164-8","DOI":"10.5588\/pha.16.0029","article-title":"Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in Zimbabwe.","volume":"6","author":"K Takarinda","year":"2016","journal-title":"Public Health Action."},{"key":"ref-93","doi-asserted-by":"publisher","first-page":"247-51","DOI":"10.5588\/pha.16.0053","article-title":"Scale-up of ART in Malawi has reduced case notification rates in HIV-positive and HIV-negative tuberculosis.","volume":"6","author":"H Kanyerere","year":"2016","journal-title":"Public Health Action."},{"key":"ref-94","doi-asserted-by":"publisher","first-page":"682-90","DOI":"10.1016\/S0140-6736(14)60162-8","article-title":"Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.","volume":"384","author":"M Rangaka","year":"2014","journal-title":"Lancet."},{"key":"ref-95","doi-asserted-by":"publisher","first-page":"808-22","DOI":"10.1056\/NEJMoa1507198","article-title":"A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.","volume":"373","author":"C Danel","year":"2015","journal-title":"N Engl J Med."},{"key":"ref-96","doi-asserted-by":"publisher","first-page":"797-801","DOI":"10.1097\/QAD.0000000000000985","article-title":"Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV.","volume":"30","author":"S Den Boon","year":"2016","journal-title":"AIDS."},{"key":"ref-97","doi-asserted-by":"publisher","first-page":"e1001842","DOI":"10.1371\/journal.pmed.1001842","article-title":"Achieving Systemic and Scalable Private Sector Engagement in Tuberculosis Care and Prevention in Asia.","volume":"12","author":"W Wells","year":"2015","journal-title":"PLoS Med."},{"key":"ref-98","doi-asserted-by":"publisher","first-page":"1424-9","DOI":"10.5588\/ijtld.15.0536","article-title":"Public-private mix for tuberculosis care and prevention. What progress? What prospects?","volume":"20","author":"M Uplekar","year":"2016","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-99","article-title":"Guide to develop a national action plan on public-private mix for tuberculosis prevention and care","year":"2017"},{"key":"ref-100","doi-asserted-by":"publisher","first-page":"310-4","DOI":"10.2471\/BLT.07.044685","article-title":"Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi.","volume":"86","author":"S Makombe","year":"2008","journal-title":"Bull World Health Organ."},{"key":"ref-101","doi-asserted-by":"publisher","first-page":"320-6","DOI":"10.2471\/BLT.05.023952","article-title":"Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi.","volume":"84","author":"E Libamba","year":"2006","journal-title":"Bull World Health Organ."},{"key":"ref-102","first-page":"923-4","article-title":"Universal tuberculosis control targets: not so smart.","volume":"13","author":"F Matthys","year":"2009","journal-title":"Int J Tuberc Lung Dis."},{"key":"ref-103","article-title":"TB Research. Putting research into policy and practice. The experience of the Malawi National Tuberculosis Programme","year":"1999"},{"key":"ref-104","doi-asserted-by":"crossref","first-page":"143-7","DOI":"10.1016\/S1472-9792(02)00061-6","article-title":"Integration of operational research into National Tuberculosis Control Programmes.","volume":"83","author":"A Harries","year":"2003","journal-title":"Tuberculosis (Edinb)."},{"key":"ref-105","doi-asserted-by":"publisher","first-page":"273-6","DOI":"10.5588\/pha.16.0044","article-title":"The effects of placing an operational research fellow within the Viet Nam National Tuberculosis Programme.","volume":"6","author":"N Hoa","year":"2016","journal-title":"Public Health Action."},{"key":"ref-106","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/s13104-017-2987-9","article-title":"Operational research within the national tuberculosis control programme in Benin.","volume":"10","author":"S Ade","year":"2017","journal-title":"BMC Res Notes."},{"key":"ref-107","doi-asserted-by":"publisher","first-page":"e720-e726","DOI":"10.1016\/S2214-109X(17)30198-5","article-title":"Innovative financing instruments for global health 2002-15: a systematic analysis.","volume":"5","author":"R Atun","year":"2017","journal-title":"Lancet Glob Health."},{"key":"ref-108","doi-asserted-by":"publisher","first-page":"939-55","DOI":"10.1007\/s40273-015-0279-6","article-title":"Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.","volume":"33","author":"Y Laurence","year":"2015","journal-title":"Pharmacoeconomics."},{"key":"ref-109","doi-asserted-by":"publisher","first-page":"111-6","DOI":"10.1016\/j.ijid.2016.10.016","article-title":"Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade.","volume":"56","author":"D Cazabon","year":"2017","journal-title":"Int J Infect Dis."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/7-1011\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1011\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1011\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T09:45:13Z","timestamp":1589276713000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/7-1011\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":109,"URL":"https:\/\/doi.org\/10.12688\/f1000research.14821.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.16130.r35652","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.16130.r35651","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,5]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/7-1011\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.16130.r35651, Keertan Dheda, Department of Medicine, University of Cape Town, Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Cape Town, South Africa, 06 Jul 2018, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1011\/v1#referee-response-35651","order":0,"name":"referee-response-35651","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.16130.r35652, Edward Nardell, Department of Environmental Health, Harvard School of Public Health, Boston, MA, USA, 06 Jul 2018, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1011\/v1#referee-response-35652","order":1,"name":"referee-response-35652","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication).","order":0,"name":"copyright-info","label":"Copyright"}]}}